Elligo Health Research
Chad Moore is the co-founder and President of Elligo Health Research - a technology-enabled services company providing easy access to both patients and physicians to participate in clinic research studies. Elligo offers the only platform that brings clinical research to physician practices, accelerating the development of new pharmaceutical, biotechnology and medical device products and therapies
Prior to Elligo, Chad was an investment banker covering the outsourced pharmaceutical services and IT sector for over a decade. Most recently, Moore was a Managing Director at Leerink Partners where he led the firm’s pharmaceutical services and IT investment banking team.
In addition, he founded and was the head of the pharmaceutical services and IT investment banking practice at Robert W. Baird & Co. Earlier in his career, Chad held positions of increasing responsibilities at PRA International (now PRA Health Sciences) where he oversaw PRA’s merger and acquisition activities and assisted in the company’s 2004 initial public offering and subsequent follow-on offering,
Chad received his B.S. from Elmhurst College and a MBA from the University of Notre Dame.